CAMP4, preparing for IPO, announces partnership with BioMarin

Regulatory RNA startup CAMP4 Therapeutics has inked another collaboration deal as it prepares for an initial public offering.

The Cambridge, MA-based startup has lined up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Genmab acquires ProfoundBio in $1.8bn deal

In April 2024 Genmab and ProfoundBio entered ia definitive agreement to execute the acquisition. Credit: ArDanMe / Shutterstock.com. Genmab has concluded the previously announced acquisition

May 22, 2024

Yale Law School’s free speech group says Boehringer’s IRA argument is ‘fundamentally flawed’

Yale Law School’s Floyd Abrams Institute for Freedom of Expression described Boehringer Ingelheim’s First Amendment arguments in its Inflation Reduction Act lawsuit as “extraordinarily troubling.” Boehringer filed

January 3, 2024

Germany’s largest medical cannabis company launches online platform for cannabis on prescription – Biotech Investments

EQS-News: Cantourage Group SE / Key word(s): Expansion Telecan°: Germany’s largest medical cannabis company launches online platform for cannabis on prescription 01.09.2023 / 09:00 CET/CEST

September 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.